JP2017511316A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017511316A5 JP2017511316A5 JP2016559626A JP2016559626A JP2017511316A5 JP 2017511316 A5 JP2017511316 A5 JP 2017511316A5 JP 2016559626 A JP2016559626 A JP 2016559626A JP 2016559626 A JP2016559626 A JP 2016559626A JP 2017511316 A5 JP2017511316 A5 JP 2017511316A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- composition
- composition according
- medicament
- psoriasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461972638P | 2014-03-31 | 2014-03-31 | |
| US61/972,638 | 2014-03-31 | ||
| US201462031850P | 2014-07-31 | 2014-07-31 | |
| US62/031,850 | 2014-07-31 | ||
| US201462041879P | 2014-08-26 | 2014-08-26 | |
| US62/041,879 | 2014-08-26 | ||
| PCT/US2015/021613 WO2015153144A1 (en) | 2014-03-31 | 2015-03-19 | Methods of treating nail and scalp psoriasis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017511316A JP2017511316A (ja) | 2017-04-20 |
| JP2017511316A5 true JP2017511316A5 (enExample) | 2019-05-09 |
| JP6596014B2 JP6596014B2 (ja) | 2019-10-23 |
Family
ID=52808190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016559626A Active JP6596014B2 (ja) | 2014-03-31 | 2015-03-19 | 爪および頭皮乾癬の治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20170174772A1 (enExample) |
| EP (1) | EP3126392B1 (enExample) |
| JP (1) | JP6596014B2 (enExample) |
| KR (2) | KR20160130248A (enExample) |
| CN (1) | CN106456751B (enExample) |
| AU (1) | AU2015241373B2 (enExample) |
| CA (1) | CA2944605C (enExample) |
| ES (1) | ES2760002T3 (enExample) |
| MY (1) | MY184189A (enExample) |
| SG (1) | SG11201607881SA (enExample) |
| WO (1) | WO2015153144A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7767206B2 (en) | 2006-10-02 | 2010-08-03 | Amgen Inc. | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
| PH12012501364A1 (en) | 2010-01-15 | 2012-10-22 | Amgen K A Inc | Antibody formulation and therapeutic regimens |
| CN105534996B (zh) * | 2016-02-24 | 2018-05-01 | 长沙佰顺生物科技有限公司 | 一种治疗银屑病的药物组合物 |
| GB201612043D0 (en) * | 2016-07-11 | 2016-08-24 | Crescendo Biologics Ltd | Composition for treatment of disorders |
| JP7033774B2 (ja) * | 2017-08-25 | 2022-03-11 | 国立大学法人 東京大学 | 抗サイトカイン抗体療法 |
| US12161748B2 (en) | 2018-01-31 | 2024-12-10 | Twi Biotechnology, Inc. | Topical formulations comprising tofacitinib |
| SG11202006782YA (en) * | 2018-01-31 | 2020-08-28 | Twi Pharmaceuticals Inc | Topical formulations comprising tofacitinib |
| AU2019224354A1 (en) | 2018-02-22 | 2020-10-08 | Nippon Zoki Pharmaceutical Co., Ltd. | IL-17a activity inhibitor and use thereof |
| AU2019282155A1 (en) * | 2018-06-04 | 2021-01-07 | Lars BRICHTA | Topical compositions for stimulating hair growth |
| CN120241997A (zh) | 2019-02-18 | 2025-07-04 | 伊莱利利公司 | 治疗性抗体制剂 |
| EP4028053A1 (en) * | 2019-09-11 | 2022-07-20 | Bausch Health Ireland Limited | Methods of treating nonalcoholic fatty liver disease (nafld) using il-17ra antibody |
| KR20220070244A (ko) * | 2019-09-25 | 2022-05-30 | 도꾜 다이가꾸 | 전신성 강피증 치료용 의약 조성물 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| IL83878A (en) | 1987-09-13 | 1995-07-31 | Yeda Res & Dev | Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it |
| IL98078A0 (en) | 1991-05-07 | 1992-06-21 | Yeda Res & Dev | Pharmaceutical compositions comprising an anticytokyne |
| US5204244A (en) | 1987-10-27 | 1993-04-20 | Oncogen | Production of chimeric antibodies by homologous recombination |
| GB8807803D0 (en) | 1988-03-31 | 1988-05-05 | Glaxo Group Ltd | Biochemical product |
| WO1989009622A1 (en) | 1988-04-15 | 1989-10-19 | Protein Design Labs, Inc. | Il-2 receptor-specific chimeric antibodies |
| IL94039A (en) | 1989-08-06 | 2006-09-05 | Yeda Res & Dev | Antibodies to tbp - 1 and their use |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5116964A (en) | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
| DK0393438T3 (da) | 1989-04-21 | 2005-05-30 | Amgen Inc | TNF-receptor, TNF-bindende proteiner og DNAér, der koder herfor |
| DE3922089A1 (de) | 1989-05-09 | 1990-12-13 | Basf Ag | Neue proteine und ihre herstellung |
| AU636608B2 (en) | 1989-05-18 | 1993-05-06 | Yeda Research And Development Co. Ltd. | Tumor necrosis factor binding protein II, it's purification and antibodies thereto |
| IL95031A (en) | 1989-07-18 | 2007-03-08 | Amgen Inc | Method for the production of a human recombinant tumor necrosis factor inhibitor |
| US5395760A (en) | 1989-09-05 | 1995-03-07 | Immunex Corporation | DNA encoding tumor necrosis factor-α and -β receptors |
| WO1991003553A1 (en) | 1989-09-05 | 1991-03-21 | Immunex Corporation | TUMOR NECROSIS FACTOR-α AND -β RECEPTORS |
| EP0939121B2 (de) | 1989-09-12 | 2007-12-26 | AHP Manufacturing B.V. | TFN-bindende Proteine |
| JPH03127800A (ja) | 1989-10-13 | 1991-05-30 | Teijin Ltd | 腫瘍壊死因子活性抑制物質 |
| AU642938B2 (en) | 1989-12-13 | 1993-11-04 | Yeda Research And Development Co. Ltd. | Expression of the recombinant tumor necrosis factor binding protein 1 (TBP-1) |
| US5136021A (en) | 1990-02-27 | 1992-08-04 | Health Research, Inc. | TNF-inhibitory protein and a method of production |
| US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
| US6458360B1 (en) | 1990-04-25 | 2002-10-01 | The Johns Hopkins University | Soluble complement regulatory molecules |
| GB2246569A (en) | 1990-06-15 | 1992-02-05 | Charing Cross Sunley Research | Tumour necrosis factor - alpha binding protein |
| DK0464533T3 (da) | 1990-06-28 | 1999-04-26 | Gen Hospital Corp | Fusionsproteiner med immunglobulindele, deres fremstilling og anvendelse |
| WO1992001002A1 (en) | 1990-07-11 | 1992-01-23 | Teijin Limited | Tumor necrosis factor activity inhibitor and production thereof |
| ES2145744T5 (es) | 1991-01-18 | 2008-02-01 | Amgen Inc. | Procedimientos para tratar las enfermedades inducidas por el factor de necrosis tumoral. |
| ATE240740T1 (de) | 1991-03-15 | 2003-06-15 | Amgen Inc | Pegylation von polypeptiden |
| IL99120A0 (en) | 1991-08-07 | 1992-07-15 | Yeda Res & Dev | Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them |
| WO1993007863A1 (en) | 1991-10-15 | 1993-04-29 | Mullarkey Michael F | Methods and compositions for treating allergic reactions |
| ATE242322T1 (de) | 1992-03-30 | 2003-06-15 | Immunex Corp | Fusionsprotein , das zwei rezeptoren des tumornekrose-faktors enthält |
| ATE188610T1 (de) | 1992-04-30 | 2000-01-15 | Amgen Inc | Methoden zur behandlung von interleukin- 1 und - tumor - nekrose - faktor - verursachten krankheiten |
| JPH05312248A (ja) | 1992-05-08 | 1993-11-22 | Nissan Motor Co Ltd | シフトレバー装置 |
| AU670125B2 (en) | 1992-09-15 | 1996-07-04 | Immunex Corporation | Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| ES2156149T3 (es) | 1992-12-04 | 2001-06-16 | Medical Res Council | Proteinas de union multivalente y multiespecificas, su fabricacion y su uso. |
| NZ306653A (en) | 1995-03-23 | 1999-03-29 | Immunex Corp | Isolated dna il-17 receptors |
| US7030565B2 (en) | 2004-07-27 | 2006-04-18 | Jerrell Penn Hollaway | Lamp control circuit with selectable color signals |
| BRPI0611901A2 (pt) | 2005-06-14 | 2012-08-28 | Amgen, Inc | composição, liofilizado, kit, e, processo para preparar uma composição |
| UA99716C2 (ru) * | 2006-10-02 | 2012-09-25 | Кирин-Амген Инк. | Антитело, которое специфично связывает человеческий il-17 рецептор а (il-17ra) |
| US7767206B2 (en) | 2006-10-02 | 2010-08-03 | Amgen Inc. | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
| PH12012501364A1 (en) | 2010-01-15 | 2012-10-22 | Amgen K A Inc | Antibody formulation and therapeutic regimens |
| CN103154031A (zh) * | 2010-10-08 | 2013-06-12 | 诺华有限公司 | 利用il-17拮抗剂治疗牛皮癣的方法 |
| US9413463B2 (en) | 2013-08-30 | 2016-08-09 | Google Inc. | Apparatus and method for efficient two-way optical communication where transmitter may interfere with receiver |
| US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
-
2015
- 2015-03-19 CA CA2944605A patent/CA2944605C/en active Active
- 2015-03-19 CN CN201580017495.1A patent/CN106456751B/zh active Active
- 2015-03-19 ES ES15714136T patent/ES2760002T3/es active Active
- 2015-03-19 KR KR1020167026333A patent/KR20160130248A/ko not_active Ceased
- 2015-03-19 JP JP2016559626A patent/JP6596014B2/ja active Active
- 2015-03-19 AU AU2015241373A patent/AU2015241373B2/en active Active
- 2015-03-19 KR KR1020227021274A patent/KR102530900B1/ko active Active
- 2015-03-19 EP EP15714136.7A patent/EP3126392B1/en active Active
- 2015-03-19 US US15/129,811 patent/US20170174772A1/en not_active Abandoned
- 2015-03-19 SG SG11201607881SA patent/SG11201607881SA/en unknown
- 2015-03-19 MY MYPI2016001729A patent/MY184189A/en unknown
- 2015-03-19 WO PCT/US2015/021613 patent/WO2015153144A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017511316A5 (enExample) | ||
| CA2944605C (en) | Methods of treating nail and scalp psoriasis | |
| JP6554155B2 (ja) | Ｉｌ−１７アンタゴニストを使用して汎発性膿疱性乾癬（ｇｐｐ）を処置する方法 | |
| JP2025172841A (ja) | Ｉｌ－４ｒアンタゴニストを投与することによるアトピー性皮膚炎の治療方法 | |
| US20230303677A1 (en) | Methods of treating new-onset plaque type psoriasis using il-17 antagonists | |
| KR20200088857A (ko) | Il-17 길항제에 의한 화농성 한선염의 치료 | |
| JP2023520676A5 (enExample) | ||
| JP2024530954A5 (enExample) | ||
| JP2024532263A5 (enExample) | ||
| CA3225933A1 (en) | Il-13 antibodies for the treatment of atopic dermatitis | |
| US20250042985A1 (en) | Interleukin 5 binding protein dosage regimen for use in treating polyangiitis, hypereosinophilic syndrome, chronic rhinosinusitis with nasal polyps (crswnp), or chronic rhinosinusitis without nasal polyps (crssnp) | |
| CN114423455A (zh) | 用于治疗系统性硬化症的药物组合物 | |
| EP4267184B1 (en) | Interleukin 5 binding protein dosage regimen | |
| JP2024522620A5 (enExample) | ||
| JP2023534576A5 (enExample) | ||
| US20220403018A1 (en) | Methods of treating lichen planus using interleukin (il-17) antagonists | |
| WO2026078117A1 (en) | Anti-il-5 antibody in the treatment of chronic rhinosinusitis with nasal polyps | |
| CN121889429A (zh) | 用于治疗嗜酸性肉芽肿性多血管炎的IL-5R-α抗体 | |
| JP2025537966A (ja) | 潰瘍性大腸炎を治療する方法 | |
| IL316022A (en) | Method of treating mild to moderate psoriasis with il-23 specific antibody |